FilingReader Intelligence
Suven Life Sciences raises INR 1.23bn through warrant conversion
July 16, 2025 at 09:39 AM UTC•By FilingReader AI
Suven Life Sciences allotted 91.86 million equity shares at INR 134 per share through warrant conversion, raising INR 1.23bn.
The preferential allotment increased the company's paid-up equity capital to INR 2.27bn. Key investors include Quant Mutual Fund, Abakkus Diversified Alpha Fund, and Cobra India (Mauritius) Limited.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:SUVEN•Bombay Stock Exchange
News Alerts
Get instant email alerts when Suven Life Sciences publishes news
Free account required • Unsubscribe anytime